Bronstein, Gewirtz & Grossman, LLC Files Class Action Lawsuit Against TELUS International On February 17, 2025, Bronstein, Gewirtz & Grossman, LLC, a prominent law firm, announced the filing of a class action lawsuit against TELUS International (Cda) Inc. (TELUS) and certain of its officers. The lawsuit alleges that the Company and its executives violated federal…
The Most Expensive Books and Manuscripts in History Introduction Throughout history, humans have recorded their knowledge, ideas, and stories in written form. As a result, books and manuscripts hold an important place in preserving history, ideas, and creativity. Some of these written works have commanded astronomical prices due to their rarity, significance, age, beauty or…
Transaction in Own Shares 11 December, 2024 Shell plc (the ‘Company’) announces that on 11 December 2024 it purchased the following number of Shares for cancellation. Aggregated information on Shares purchased according to trading venue: Date of purchase 11/12/2024 Number of Shares purchased 1,150,000 Highest price paid £25.1850 Lowest price paid £24.8300 Volume weighted average…
Altcoin Season: Waiting for the Big Bang Is Altcoin Season Finally Upon Us? As cryptocurrency enthusiasts eagerly await the much-anticipated altcoin season, the buzz in the community is palpable. For those unfamiliar with the term, altcoin season refers to a period in the cryptocurrency market where investors start rotating their capital into alternative cryptocurrencies, also…
The Canary in the SUI Coal Mine: The First ETF is Nesting Hey there, human! I’ve got some exciting scoops for you. It looks like the world of decentralized finance (DeFi) is about to take another giant leap forward. Can you believe it? The first Exchange-Traded Fund (ETF) on the Solana Blockchain (SUI) might be…
Tiziana Life Sciences Announces Breakthrough Study Results in Traumatic Spinal Cord Injury New York, Jan. 23, 2025 (GLOBE NEWSWIRE) — Tiziana Life Sciences, Ltd. (Nasdaq: TLSA) (“Tiziana” or the “Company”), a biotechnology company developing breakthrough immunomodulation therapies with its lead development candidate, intranasal foralumab, a fully human, anti-CD3 monoclonal antibody, today announced results from studies…
Unleashing the Potential: Discover Why This Altcoin with a $400M Market Cap Deserves a Spot on Your Watchlist – Hint: 500% Upside! The post Why Is This Altcoin With $400M Worthy To Be On Your Watchlist? Hint: 500% Upside Amid the bullish reversal in Bitcoin, the altcoins are presenting a trend reversal opportunity for massive…
HP’s Q3 Earnings Miss Estimates: A Closer Look HP Inc. (HPQ), the global technology company known for its innovative hardware and software solutions, recently reported its third-quarter earnings for fiscal year 2023. The earnings report, which sent a ripple through the tech industry, revealed that HP’s earnings came in at $0.74 per share, missing the…
